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BACKGROUND: Age is an important determinant of the pharmacokinetic profile of
inhaled anesthetics. The influence of age on the dynamic profile of sevoflurane’s
effect has not been well described. We performed this study to characterize the
influence of age and other covariates on the dynamic relationship between
sevoflurane end-tidal concentration (CET) and its effect measured by bispectral
index (BIS).
METHODS: Fifty patients, aged 3–71 yr, scheduled for minor surgery were prospec-
tively studied. The BIS and sevoflurane CET were continuously measured during
the study period. During maintenance of anesthesia and after stable BIS values of
60–65 were obtained, the inspired concentration of sevoflurane was increased to 5
vol % for 5 min or until BIS 40 and then decreased. The dynamic relationship
between sevoflurane CET and its effect as measured by BIS during this transition
period were modeled with an inhibitory Emax model using a population pharma-
cokinetic–pharmacodynamic approach with NONMEM V. A predictive check
method was used to validate the final model.
RESULTS: The sensitivity to sevoflurane’s effect as measured by BIS expressed in the
C50 [steady-state CET eliciting half of maximum response (Imax)] increased with age.
The speed of change of sevoflurane’s effect, expressed as the effect–site equilibra-
tion half-life (t1/2 ke0), increased at older ages. The predictive check analysis
confirmed the adequacy of the model.
CONCLUSIONS: Age significantly affects the dynamic relationship between sevoflu-
rane CET and its effect measured with BIS.
(Anesth Analg 2008;107:1566–72)
Volatile anesthetics exert their hypnotic effect in the
brain. Normally, end-tidal concentrations (CET) of
these drugs are used as indirect measures of their
brain concentration at stable anesthetic depths. How-
ever, during transitions of the anesthetic depth level,
delays between CET and the concentration in the
effect–site (Ce) occur.
1 Pharmacokinetic–pharmacody-
namic (PK-PD) modeling has allowed the quantifica-
tion of these delays incorporating the plasma–effect
site equilibration rate constant (ke0).
2 This has led to a
greater understanding of the clinical properties of
these anesthetics in terms of onset, dosing, and offset
of effect.
The influence of age on the dynamic relationship
between the CET and the hypnotic effect of volatile
anesthetics has not been explored with PK-PD mod-
eling. In theory, a decrease in the proportion of cardiac
output directed to the vessel-rich tissues3 and an
increase in tissue and blood solubility of inhaled
anesthetics with age4 should result in progressively
slower onset and offset of the effect measured by
bispectral index (BIS). These assumptions, however,
do not consider possible influences of cortical and
subcortical neuronal dynamics that might be affected
by age.5
The aim of this study was to characterize the
influence of age and other covariates on the dynamic
relationship between sevoflurane CET and its effect
measured with BIS [Aspect A-2000 BIS® monitor (ver-
sion XP)].
METHODS
After IRB approval (School of Medicine, Pontificia
Universidad Cato´lica, Santiago, Chile) and obtaining
written informed consent, 50 patients with ASA physi-
cal status I or II, aged 3–71 yr, were prospectively
studied. All patients were unpremedicated and sched-
uled to undergo general anesthesia for minor elective
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surgery. Exclusion criteria were any known cerebro-
vascular disease, long- or short-term (within the pre-
vious 24 h) intake of any drug acting in the central
nervous system, and any known adverse effect to the
study drugs.
In the operating room, after standard monitoring,
anesthesia was induced either by sevoflurane inhala-
tion or by an IV bolus of propofol 1–2 mg/kg. If
tracheal intubation was part of the anesthetic plan,
fentanyl 1–3 g/kg and rocuronium 0.6 mg/kg were
also administered. After induction, the airway was
secured either with a laryngeal mask airway or with
an endotracheal tube, and patients’ lungs were me-
chanically ventilated to obtain an end-tidal carbon
dioxide of approximately 35 mm Hg. Peak airway
pressure was maintained under 20 cm H2O and con-
firmation that no gas leaked by auscultation was also
checked at this stage. Maintenance of anesthesia was
with sevoflurane and oxygen. No more hypnotic
drugs, opioids, or muscle relaxants were given until
the study was finished.
During the maintenance period of anesthesia, pa-
tients were monitored with the Aspect A-2000 BIS®
monitor (version XP). The skin was prepared to ensure
low impedance and good quality of signal and the
sensors were attached according to the manufacturer’s
recommendations. The pediatric sensors and the
QUATRO sensors were used for children (15 yr) and
adult patients, respectively, and the smoothing time
period was set at 15 s.
The study was performed during maintenance of
anesthesia either before or after surgery. Patients who
received propofol and/or fentanyl during induction
were studied at the end of surgery after a period of at
least 45-min from induction to minimize the influence
of propofol or fentanyl on BIS. During the study
period, the patients were kept undisturbed with the
operating room in silence and without any surgical or
tactile stimulation. No arterial blood pressure mea-
surements were allowed at this time. Fresh oxygen
flow was set at 5 L/min and sevoflurane concentra-
tions were gradually decreased to obtain relatively
stable BIS values of 60–65. After 5 min of stable BIS
values (baseline period), sevoflurane inspired concen-
trations were then increased to 5 vol % for a maximum
of 5 min or until BIS reached values 40. The vapor-
izer was then closed until BIS returned to basal values
(60–65). At this point, the study was finished and
anesthesia continued according to the anesthesiolo-
gist’s criteria. During the study period, BIS values and
expiratory sevoflurane concentrations, measured by a
Datex Capnomac monitor (Datex, Helsinski, Finland),
were manually recorded every 10 s.
A parametric approach was used to model the
effect of sevoflurane measured with BIS. In this ap-
proach, it was assumed that CET sevoflurane reflects
its plasma concentration (Cp) and that predicted
sevoflurane concentrations in the effect compartment
were linked to Cp through a first-order process as it is
shown in Eq. 1.
dCe
dt
 ke0 Cp Ce (1)
where dCe/dt represents the rate of change of Ce and
ke0 is the first-order rate constant of equilibrium
between plasma and biophase. The relation between
the Ce and the BIS effect was mathematically modeled.
The PD model used to fit the BIS effect data was the
inhibitory sigmoidal Imax model (Eq. 2).
E E0  1 Imax CeCe  C50  (2)
where E is the BIS value being measured, E0 is the BIS
value in the absence of sevoflurane, Imax is the maxi-
mum decrease in the response that the sevoflurane can
elicit and can range from 0 to 1, C50 is the steady-state
plasma concentration of sevoflurane eliciting half of
Imax, and  is the steepness of the concentration–
response curve. The model parameters were esti-
mated using a population analysis with NONMEM
version V (Globomax LLC, Hanover, MD).6 Interin-
dividual variability was modeled using an exponen-
tial model (Eq. 3).
Pi  PTV ei (3)
where Pi is the parameter value (E0, Imax, , or C50) in
the ith patient, PTV is the typical value of the param-
eter in the population, and  is a random variable with
a mean of 0 and variance of 	.2 Residual intraindi-
vidual variability was modeled with an additive error
model. The FOCE with INTERACTION estimation
method, together with the subroutine ADVAN6
TOL  5, was used during the analysis.
Model selection was based mainly on the inspection
of goodness-of-fit plots and the precision of the pa-
rameter estimates. The minimum value of the objec-
tive function [2  log-likelihood (2LL)] provided by
NONMEM served as a guide during model building.
For two nested models, a decrease in 2LL of 3.84 or
6.63 points for an added parameter is considered
significant at the 0.05 or 0.01 level, respectively.
Results from the population models are presented
as parameter estimates, together with the correspond-
ing relative standard error. These last values are
computed as the ratio between the standard error and
the estimate of the parameter. Interindividual variabil-
ity is expressed as coefficient of variation [CV (%)].
In our modeling approach, we first developed the
base population model, which better described the
data. At this stage of the analysis, no covariates were
included in the model. The effects of age, weight,
gender, lean body mass height, and heart rate were
then explored. Allometric scaling of weight was tested
at this stage. Covariates selection was performed
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using the GAM method7 implemented in Xpose 3.1
program (a population PK-PD model building program
for NONMEM found at http://sourceforge.net).8 To
determine the relevant covariates of the final model, a
forward inclusion and backward elimination ap-
proach was used in consecutive NONMEM runs.9
During the forward inclusion and backward elimi-
nation approaches, the levels of significance used
were 0.05 and 0.01, respectively.
The final population model was evaluated by visual
predictive check10: 100 datasets of the same character-
istics of the original dataset were simulated using the
final population PD model. The 5th, 50th, and 95th
percentiles of the BIS versus time simulated profiles
were first computed for patients (i) younger than 20
years, (ii) between 20 and 50 yr, and (iii) older than 50
yr, and then plotted together with the corresponding
raw data.
The impact of the selected covariates on the
sevoflurane dynamic profile was further explored
using simulations based on the selected model as
follows: The average sevoflurane CET time profile was
calculated from all the individual time profiles mea-
sured in our patients. This average sevoflurane time
profile was then used to generate typical population
BIS time profiles for different representative values of
the selected covariates.
RESULTS
All patients (n  50) were included in the analysis.
Demographic and general data observed during the
study period are summarized in Table 1. The observed
time course of sevoflurane CET and BIS is shown in
Figure 1.
The selected base population model consisted of a
sigmoidal model with interindividual variability esti-
mated for C50, , and ke0. Since we did not measure BIS
before sevoflurane administration, we fixed E0 to 97,
an allowed a 5% interindividual variability for this
parameter, and Imax was fixed to 1. In this model, the
time course of Cp was described by linear interpola-
tion. The parameter estimates of the base population
model are shown in Table 2, where it can be observed
that all of the parameters were estimated with very
good precision.
During the covariate model selection, only age was
found to be a significant covariate for C50 and ke0 (P 
0.01). This variable was explored as a continuous and
as a categorical variable (children 10 yr  1; patients
10 yr  2) during this process. The relationship
between these parameters and their covariates is
shown in Figure 2. The typical parameter values of C50
and ke0 for the median age subject are 1.49% and 0.383
min1, values very close to the ones obtained in the
base population model and listed in Table 2.
Table 3 lists the model parameter estimates of the
final selected model where again parameter precision
was high. Figure 3 shows two goodness-of-fit plots
consisting of the relationship between the observa-
tions and the individual model predictions (left
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Figure 1. Time course of the measured end-tidal sevoflurane
concentrations values (top panel) and time course of the
measured bispectral index values (bottom panel) in all
patients.
Table 2. Population Pharmacokinetics/Pharmacodynamic
Parameters of Sevoflurane in the Final Base Population Model
Parameter
Typical population
value (PTV)
Interindividual
variability (	2)
E0 (BIS) 97 fixed 5 fixed
C50 (%) 1.5 (0.04) 27.7 (0.17)
Imax 1 fixed —
ke0 (min
1) 0.38 (0.05) 36.6 (0.22)
 1.2 (0.06) 36.7 (0.23)
Residual error
(sd)
4.6 (0.06) —
Minimum value of the objective function  8728.
Estimates are presented together with the corresponding relative standard errors in
parenthesis. Estimates of interindividual variability are expressed as CV (%). Parameters are
defined in the text.
SD  standard deviation; BIS  bispectral index.
Table 1. Demographic and General Data
Age (yr) 34  21 (3–71)
Female/male ratio (n) 26/24
Weight (kg) 60 23 (14–99)
Height (cm) 155 34 (92–185)
Baseline mean arterial pressure
(mm Hg)
69  13 (45–97)
Baseline cardiac rate (bpm) 66 18 (42–116)
Baseline BIS value 63 3 (60–70)
Minimum BIS value 31 5 (18–39)
Duration of study period (min) 6.6 1.8 (4–11)
n  50; values are mean  SD (range).
BIS  bispectral index.
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panel), and the ratio between individual model pre-
dictions and observed values versus time (right
panel). No major tendencies are present in the graph-
ics indicating a very good model performance. Figure
4 shows the relationship between the sevoflurane CET
and BIS (left panel), and the relationship between the
predicted sevoflurane Ce and BIS (right panel) where
an adequate collapse of the hysteresis loop is ob-
served. Table 4 shows typical estimates of t1/2 ke0
values according to age, where t1/2 ke0  ln 2/ke0.
Results from the visual predictive check are shown
in Figure 5, which shows that the final population
model adequately captures the mean tendencies of the
data and their dispersion.
Finally, the effect of age in BIS time profiles evalu-
ated by computed simulations is presented in Figure
6. The values of age used for the simulations corre-
spond to the 5th, 50th, and 95th percentiles of the
distribution with the studied population.
DISCUSSION
The main finding of this study is that the dynamic
relationship between sevoflurane CET and its effect
measured with BIS are affected by age. Although the
sensitivity to sevoflurane measured with BIS effect
expressed in the C50 increases with age, the speed of
change of sevoflurane’s effect expressed in the t1/2 ke0
is slower at older ages.
Katoh et al.11 analyzed the influence of age on the
hypnotic requirement of sevoflurane using BIS and
spectral edge frequency. In this study, 96 patients
Age (yr)
0 20 40 60 80
C
50
 (v
ol
 %
) 
0.8
1.0
1.2
1.4
1.6
1.8
2.0
2.2
2.4
2.6
2.8
Age (yr)
0 20 40 60 80
K
e0
 (m
in
-1
)
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
Figure 2. Two scatter plots of the
parameter–covariate relationships in-
cluded in the final model. Left panel:
C50–age relationship. Right panel:
ke0–age relationship. The solid lines
represent the covariate model predic-
tions based on the typical values of
the parameters. The good quality of
the fit corroborates the parameters–
covariate relationship used in the
model.
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Figure 3. Goodness of fit plots corre-
sponding to the final model. Left
panel: Relationship between indi-
vidual model predictions and obser-
vations. The solid line represents the
line of identity. Right panel: Ratio
between observed and individual
model predicted bispectral index val-
ues versus time. Horizontal line rep-
resents the perfect prediction (y  1).
Table 3. Population Pharmacokinetics/Pharmacodynamic Parameters of Sevoflurane in the Final Covariate Population Model
Parameter Typical population value (PTV) Interindividual variability (	
2)
E0 (BIS) 97 fixed 5 fixed
C50  
1  	1 
 
2  (age-33.5) 
1(%) 1.49 (0.04) 25.3 (0.17)

2(age
1)  0.0052 (0.31)
Imax 1 fixed —
ke0  
3  	1 
 
4  (age-33.5) 
3(min
1)  0.383 (0.05) 31 (0.22)

4(age
1)  0.0084 (0.23)
 1.18 (0.05) 36.7 (0.24)
Residual error (sd) 4.6 (0.065) —
Minimum value of the objective function  8706.
Estimates are presented together with the corresponding relative standard error in parenthesis. Estimates of interindividual variability are expressed as CV (%). Parameters are defined in the text.
SD  standard deviation; BIS  bispectral index.
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from 18 to 80 yr were sedated with different concen-
trations of sevoflurane and the depth of sedation was
assessed with the Observer Assessment of Alertness
and Sedation rating scale. The authors showed that
age reduced MAC-awake, but did not change BIS and
95% spectral edge frequency associated with response
to a verbal command. In agreement with this and
other previous studies,11–13 our analysis using an
effect compartment model linked with an Imax model
showed that age significantly reduced the require-
ments of sevoflurane. The C50 estimated is comparable
to previous values reported in adult patients.1,14
The slower speed of sevoflurane’s effect observed
in elderly patients compared with younger patients
(Table 4) is consistent with the decrease in the propor-
tion of cardiac output directed to the vessel-rich
tissues3 and the increase in tissue and blood solubility
of inhaled anesthetics with age.4 As it can be seen in
the simulation analysis (Fig. 6), age differences in the
speed of sevoflurane’s effect during induction are less
evident than during recovery. This is probably ex-
plained by the greater sensitivity observed at older
ages, since the same sevoflurane dose scheme was
used in all patients for this simulation. Our results
showing longer times for sevoflurane end-tidal brain
equilibration in elderly patients is also consistent with
the results reported for other drugs, such as remifen-
tanil, where blood–brain equilibration times increase
nearly threefold in elderly patients compared with
younger patients.15 The current results, however, can-
not be extrapolated to other more soluble volatile
anesthetics, since the alveolar concentration of a
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Figure 4. Left panel: Relationship be-
tween end-tidal sevoflurane concentra-
tion and bispectral index (BIS) revealing
a hysteresis loop. Right panel: Relation-
ship between the effect–site sevoflurane
concentrations against BIS. The collapse
of the hysteresis loop is observed.
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Figure 5. Results from the visual pre-
dictive check. Lines represents the 5th,
95th (dashed), and 50th (solid) percen-
tiles bispectral index versus time pro-
files computed from one hundred model
based simulated datasets. Open circles
represent raw data.
Table 4. Typical t1/2 ke0 Values According to Age
Age (yr) t1/2 ke0 (min)
5 1.46
25 1.69
50 2.1
75 2.78
Estimates are derived from the typical values of the final covariate population model
parameters.
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highly soluble agent is much more influenced by
changes in cardiac output. This means that the de-
crease in cardiac output associated with aging might
result in the faster increase of the alveolar concentra-
tion of a soluble anesthetic and, consequently, faster
speed of anesthetic effect might be observed in elderly
patients with these agents.3
It should be considered that we assumed that the
sevoflurane CET reflected its plasma concentration.
This is important because the t1/2 ke0 estimates not
only represent the blood–brain equilibration time but
also the end-tidal to plasma equilibration time. In
addition, since BIS was used as the measured re-
sponse, time delays in BIS calculation will also be
represented in the t1/2 ke0 estimates.
Making the Cp of volatile anesthetics available
improves the titration of these drugs during clinical
anesthesia.16 Using children and adult data, we were
able to demonstrate that the observed ke0 variability in
this population produced significant changes in
sevoflurane’s effect. For example, the t1/2 ke0 in a
typical patient of 75 yr was found to be almost twice
that observed in a typical patient of 5 yr (Table 4). The
clinical implication of this difference is clearly shown
in the slower changes of offset of sevoflurane’s effect
in elderly patients (Fig. 6). Since this is the first study
analyzing the influence of age and other covariates in
sevoflurane t1/2 ke0, the inclusion of our findings
would be helpful in refining sevoflurane predictive
models.
One limitation of this study is that age-related
changes in the electroencephalogram (EEG) might
influence our results, since BIS has been shown to be
associated with age.17 However, most maturational
EEG changes occur early in life (1 yr). In Davidson et
al.’s study,18 the authors describe that awake BIS
values in children between 1 and 15 yr were similar to
values reported in adult patients and that the relation-
ship between sevoflurane concentration and BIS re-
sponse during emergence of anesthesia in children
between 1 and 15 yr was also consistent with adult
studies. We arbitrarily excluded children 3 yr to
avoid potential influences of maturational EEG
changes. In addition, since we only studied 11
patients 10 yr, it might also be argued that more
children would have been required to adequately
represent the important physiological changes that
occur in children.
We conclude that age significantly affects the dy-
namic relationship between sevoflurane CET and its
effect measured with BIS. Future development of an
on-line available sevoflurane PK-PD model, including
this variable, might lead to better predictability and
control of sevoflurane’s effect in our patients.
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